Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ginkgo Bioworks Holdings, Inc. (DNA)

1.78   0.05 (2.89%) 09-27 16:00
Open: 1.94 Pre. Close: 1.73
High: 2.07 Low: 1.75
Volume: 42,501,258 Market Cap: 3,736(M)

Technical analysis

as of: 2023-09-27 4:18:47 PM
Short-term rate:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Mid-term rate:       
Target: Six months: 2.5     One year: 2.87
Support: Support1: 1.62    Support2: 1.34
Resistance: Resistance1: 2.14    Resistance2: 2.46
Pivot: 1.9
Moving Average: MA(5): 1.75     MA(20): 1.99
MA(100): 1.85     MA(250): 1.85
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 7.2     %D(3): 4.7
RSI: RSI(14): 41.2
52-week: High: 3.51  Low: 1.12
Average Vol(K): 3-Month: 21,853 (K)  10-Days: 19,896 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ DNA ] has closed above bottom band by 28.0%. Bollinger Bands are 13.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.81 - 1.82 1.82 - 1.83
Low: 1.69 - 1.7 1.7 - 1.71
Close: 1.72 - 1.73 1.73 - 1.74

Company Description

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Headline News

Wed, 27 Sep 2023
MillerKnoll, Hayward Holdings, Ginkgo Bioworks And Other Big ... - UK

Wed, 27 Sep 2023
Pfizer Is Sending Ginkgo Bioworks (DNA) Stock Higher: Here's Why - Ginkgo Bioworks Holdings (NYSE:DNA) - Benzinga

Wed, 27 Sep 2023
Ginkgo Bioworks Holdings Inc (DNA) is higher by 10.40% Wednesday In Premarket Trading - InvestorsObserver

Mon, 25 Sep 2023
2023-09-25 | NYSE:DNA | Press Release | Ginkgo Bioworks ... - Stockhouse Publishing

Sat, 23 Sep 2023
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Insider Sells ... - MarketBeat

Fri, 15 Sep 2023
Is Ginkgo Bioworks Holdings Inc (DNA) a Stock to Watch After Losing -6.73% This Week? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 1,600 (M)
Shares Float 1,180 (M)
% Held by Insiders 8.3 (%)
% Held by Institutions 80.9 (%)
Shares Short 207,170 (K)
Shares Short P.Month 214,590 (K)

Stock Financials

EPS -0.64
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.72
Profit Margin (%) 0
Operating Margin (%) -393.7
Return on Assets (ttm) -37.5
Return on Equity (ttm) -79.6
Qtrly Rev. Growth -44.3
Gross Profit (p.s.) 0.17
Sales Per Share 0.2
EBITDA (p.s.) -0.77
Qtrly Earnings Growth 0
Operating Cash Flow -297 (M)
Levered Free Cash Flow 137 (M)

Stock Valuations

PE Ratio -2.79
PEG Ratio -0.2
Price to Book value 2.47
Price to Sales 8.73
Price to Cash Flow -9.59

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.